Connaissances actuelles sur la toux apparue dans un contexte gastroentérologique Fulltext Access 6 Pages 2006
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated Radiotherapy Fulltext Access 6 Pages 2006
Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327) Fulltext Access 6 Pages 2006
Misclassification of Bronchioloalveolar Carcinoma with Cytologic Diagnosis of Lung Cancer Fulltext Access 6 Pages 2006
How could pulmonary cryptococcosis in immunocompetents be suspected? Report of 6 cases Fulltext Access 6 Pages 2006
Approche diagnostique et prise en charge initiales de la toux native par le médecin spécialiste Fulltext Access 6 Pages 2006
Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer Fulltext Access 6 Pages 2006
BK Viral Reactivation in Cardiac Transplant Patients: Evidence for a Double-hit Hypothesis Fulltext Access 6 Pages 2006
Effects of Growth Hormone Therapy in Children After Cardiac Transplantation Fulltext Access 6 Pages 2006
Cytokine Gene Polymorphisms Are Not Associated With Bronchiolitis Obliterans Syndrome or Survival After Lung Transplant Fulltext Access 6 Pages 2006
Effects of Blockade of the Renin-Angiotensin and Endothelin Systems on Experimental Bronchiolitis Obliterans Fulltext Access 6 Pages 2006
Impact of Repetitive Episodes of Antibody-mediated or Cellular Rejection on Cardiovascular Mortality in Cardiac Transplant Recipients: Defining Rejection Patterns Fulltext Access 6 Pages 2006
Ventricular Assist Devices and Aggressive Immunosuppression: Looking Beyond Overall Survival Fulltext Access 6 Pages 2006
Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity Fulltext Access 6 Pages 2006
Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer Fulltext Access 6 Pages 2006
Prognosis of patients with resected non-small cell lung cancer: Impact of clinical and pathologic variables Fulltext Access 6 Pages 2006
Phase II Trial of Gemcitabine-Carboplatin-Paclitaxel as Neoadjuvant Chemotherapy for Operable Non-small Cell Lung Cancer Fulltext Access 6 Pages 2006
Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up Fulltext Access 6 Pages 2006
Lack of Association between Sputum Atypia and Chronic Obstructive Pulmonary Disease Mortality Fulltext Access 6 Pages 2006
The Value of HRCT and Tc-Depreotide in the Evaluation of Pulmonary Lesions Fulltext Access 6 Pages 2006
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Fulltext Access 6 Pages 2006
Feasibility and Validity of a One-Item Fatigue Screen in a Thoracic Oncology Clinic Fulltext Access 6 Pages 2006
Survival Differences by Sex for Patients with Advanced Non-small Cell Lung Cancer on Eastern Cooperative Oncology Group Trial 1594 Fulltext Access 6 Pages 2006
A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501) Fulltext Access 6 Pages 2006
Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 Database Fulltext Access 6 Pages 2006
Manganese Superoxide Dismutase and Catalase Genetic Polymorphisms, Activity Levels, and Lung Cancer Risk in Chinese in Hong Kong Fulltext Access 6 Pages 2006
PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients Fulltext Access 6 Pages 2006
Association between Anemia Arising during Therapy and Outcomes of Chemoradiation for Limited Small-cell Lung Cancer Fulltext Access 6 Pages 2006
Radiation therapy alone in elderly with early stage non-small cell lung cancer Fulltext Access 6 Pages 2006
Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer Fulltext Access 6 Pages 2006
Impact of Skeletal Complications on Total Medical Care Costs among Patients with Bone Metastases of Lung Cancer Fulltext Access 6 Pages 2006
Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy Fulltext Access 6 Pages 2006
Surgical Patterns of Care in Operable Lung Carcinoma Treated with Radiation Fulltext Access 6 Pages 2006
Predictive Factors of Gefitinib Antitumor Activity in East Asian Advanced Non-small Cell Lung Cancer Patients Fulltext Access 6 Pages 2006
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer Fulltext Access 6 Pages 2006
Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma Fulltext Access 6 Pages 2006
A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non–Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Does Initial Staging or Tumor Histology Better Identify Asymptomatic Brain Metastases in Patients with Non–small Cell Lung Cancer? Fulltext Access 6 Pages 2006
BAC Consensus Conference, November 4-6, 2004: Epidemiology, Pathogenesis, and Preclinical Models Fulltext Access 6 Pages 2006
EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib Fulltext Access 6 Pages 2006
Development of new first-line therapeutic options for non-small-cell lung cancer Fulltext Access 6 Pages 2006
Prognostic value of DNA ploidy: 5-year follow-up of patients with resectable squamous cell carcinoma (SCC) of the lung Fulltext Access 6 Pages 2006
Cushing's syndrome secondary to bronchopulmonary carcinoid tumor: Report of two cases and literature review Fulltext Access 6 Pages 2006
Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients Fulltext Access 6 Pages 2006
Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer Fulltext Access 6 Pages 2006
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients Fulltext Access 6 Pages 2006
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1α gene define HIF-1α protein expression in non-small cell lung cancer Fulltext Access 6 Pages 2006
L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer Fulltext Access 6 Pages 2006
A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer Fulltext Access 6 Pages 2006
Transesophageal ultrasound-guided fine needle aspiration improves mediastinal staging in patients with non-small cell lung cancer and normal mediastinum on computed tomography Fulltext Access 6 Pages 2006
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population Fulltext Access 6 Pages 2006
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) Fulltext Access 6 Pages 2006
Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer Fulltext Access 6 Pages 2006
Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC): Maspin in NSCLC Fulltext Access 6 Pages 2006
Medulloblastoma in adults. A case presentation and review of the literature Fulltext Access 6 Pages 2006
Classical prognostic factors in patients with non-advanced endometrial cancer treated with postoperative radiotherapy Fulltext Access 6 Pages 2006
Assessment of different MCNP Monte Carlo codes in electron absorbed dose Fulltext Access 6 Pages 2006
Monte Carlo study of electron dose distributions produced by the elekta precise linear accelerator Fulltext Access 6 Pages 2006
Expression of selected markers in patients treated for breast cancer – based on our own data Fulltext Access 6 Pages 2006
Dosimetric verification of the dose distribution in pulsed dose rate brachytherapy Fulltext Access 6 Pages 2006
Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease Fulltext Access 6 Pages 2006
Imaging of gefitinib-related interstitial lung disease: Multi-institutional analysis by the West Japan Thoracic Oncology Group Fulltext Access 6 Pages 2006
Lung cancer with chest wall involvement: Predictive factors of long-term survival after surgical resection Fulltext Access 6 Pages 2006
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy Fulltext Access 6 Pages 2006
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer Fulltext Access 6 Pages 2006
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer Fulltext Access 6 Pages 2006
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: A multicenter phase II study Fulltext Access 6 Pages 2006
Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer Fulltext Access 6 Pages 2006
Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: A phase I study Fulltext Access 6 Pages 2006
Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC) Fulltext Access 6 Pages 2006
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer Fulltext Access 6 Pages 2006
PSA bounces after brachytherapy HDR and external beam radiation therapy for prostate cancer Fulltext Access 6 Pages 2006
Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma Fulltext Access 6 Pages 2006
Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells Fulltext Access 6 Pages 2006
Radiation-induced narrowing of the tracheobronchial tree: An in-depth analysis Fulltext Access 6 Pages 2006
Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung Fulltext Access 6 Pages 2006
Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung Fulltext Access 6 Pages 2006
Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer Fulltext Access 6 Pages 2006
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism Fulltext Access 6 Pages 2006
A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer Fulltext Access 6 Pages 2006
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients Fulltext Access 6 Pages 2006
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): A multicenter phase II study Fulltext Access 6 Pages 2006